Despite initial outlay, molecular imaging improves hospitals' economic productivity

Article

As a long-term reader of Diagnostic Imaging, I appreciated the article about my highlights talk at the SNM meeting in June ("Molecular imaging steers specialty to personalized care," August, page 43).

As a long-term reader of Diagnostic Imaging, I appreciated the article about my highlights talk at the SNM meeting in June ("Molecular imaging steers specialty to personalized care," August, page 43).

I need to make an important clarification about the economics of molecular imaging to which the article referred. Two of the economic parameters involved in healthcare are total costs of running a hospital per year and total number of hospitalized patients over the same period. Dividing total costs per year by the number of patients taken care of per year reflects "productivity." This is the cost of taking care of each patient.

By eliminating unhelpful surgery and optimizing drug regimens, molecular imaging increases productivity. The installation and operation of a cyclotron and molecular imaging facility costs money and therefore increases total hospital expenses, but it increases the number of patients who are cared for (i.e., it improves productivity).

What we need now is quantification of economic factors in molecular imaging by re-analysis of the effect of molecular imaging before and after molecular imaging was introduced in a specific hospital. Such analyses with controls can be carried out retrospectively using previous studies of effectiveness. The controls are those patients taken care of before molecular imaging was introduced.

We need to quantify molecular imaging's effect on productivity, as well as its proven effect in helping patients.

My conclusion is that molecular imaging is effective in increasing economic productivity.

Henry Wagner, M.D.
Professor of medicine, radiology, and environmental health sciences
Johns Hopkins University
Baltimore, MD

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.